HDAC inhibitors exhibit growth inhibitory and anti-tumor activities like cell cycle arrest, inhibition of cell proliferation and induction of apoptosis in cancer cells both in vitro and tumor-bearing animals [33,34]. This evidence concerns the gene HDAC9 and neoplasm.